Femasys Inc. (NASDAQ:FEMY) Sees Large Growth in Short Interest

Femasys Inc. (NASDAQ:FEMY) was the recipient of a large growth in short interest in October. As of October 31st, there was short interest totalling 526,700 shares, a growth of 6.0% from the October 15th total of 496,900 shares. Currently, 2.6% of the company’s stock are sold short. Based on an average trading volume of 150,300 shares, the short-interest ratio is presently 3.5 days.

Femasys Stock Down 4.9 %

FEMY stock traded down $0.05 on Tuesday, reaching $0.89. 249,018 shares of the company traded hands, compared to its average volume of 332,132. The firm has a fifty day simple moving average of $1.15 and a 200-day simple moving average of $1.14. Femasys has a one year low of $0.73 and a one year high of $2.40. The company has a quick ratio of 3.26, a current ratio of 3.94 and a debt-to-equity ratio of 0.86.

Femasys (NASDAQ:FEMY) last released its earnings results on Tuesday, November 12th. The company reported ($0.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.04). The business had revenue of $0.55 million for the quarter, compared to the consensus estimate of $0.40 million. Femasys had a negative net margin of 1,435.77% and a negative return on equity of 141.49%. Sell-side analysts anticipate that Femasys will post -0.84 EPS for the current year.

Wall Street Analyst Weigh In

FEMY has been the topic of a number of research reports. Chardan Capital decreased their price objective on Femasys from $10.00 to $8.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. HC Wainwright reissued a “buy” rating and issued a $12.00 price objective on shares of Femasys in a research note on Tuesday, November 12th.

Institutional Investors Weigh In On Femasys

Hedge funds have recently modified their holdings of the company. Geode Capital Management LLC increased its holdings in Femasys by 9.2% in the 3rd quarter. Geode Capital Management LLC now owns 206,483 shares of the company’s stock valued at $229,000 after purchasing an additional 17,473 shares during the last quarter. XTX Topco Ltd lifted its stake in shares of Femasys by 123.9% during the 3rd quarter. XTX Topco Ltd now owns 32,535 shares of the company’s stock worth $36,000 after purchasing an additional 18,004 shares during the period. Aljian Capital Management LLC acquired a new stake in shares of Femasys during the 3rd quarter worth $27,000. Finally, CM Management LLC lifted its position in shares of Femasys by 6.3% during the second quarter. CM Management LLC now owns 425,000 shares of the company’s stock worth $484,000 after purchasing an additional 25,000 shares during the last quarter. 65.27% of the stock is owned by hedge funds and other institutional investors.

About Femasys

Femasys Inc, a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination.